HomeTagsTreadwell Therapeutics

Treadwell Therapeutics

Biotechnology

Treadwell Announces Initiation of Patient Dosing in TWT-203, a Phase 1b/2 study of TTK Inhibitor, CFI-402257, in Patients with ER+/Her2- Breast cancer

PR Newswire - June 15, 2022

Treadwell Therapeutics, a clinical-stage biotechnology company developing novel medicines for unmet needs in cancer, announced the initiation of patient dosing in TWT-203, its Phase...

Hot Topics

GlobalFoundries and BAE Systems Partner on Space Chip Technology

PTC and Garrett Motion Expand Partnership for Product Development

SAIC and HavocAI Partner to Link Autonomous Fleets to U.S. Navy